rs2289080

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005199.5(CHRNG):​c.445G>A​(p.Ala149Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0243 in 1,614,044 control chromosomes in the GnomAD database, including 865 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 103 hom., cov: 32)
Exomes 𝑓: 0.024 ( 762 hom. )

Consequence

CHRNG
NM_005199.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0180
Variant links:
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039532185).
BP6
Variant 2-232541468-G-A is Benign according to our data. Variant chr2-232541468-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 259667.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232541468-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.1 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNGNM_005199.5 linkc.445G>A p.Ala149Thr missense_variant Exon 5 of 12 ENST00000651502.1 NP_005190.4 P07510-1A0A6F7YAP6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNGENST00000651502.1 linkc.445G>A p.Ala149Thr missense_variant Exon 5 of 12 NM_005199.5 ENSP00000498757.1 P07510-1
CHRNGENST00000389492.3 linkc.350+757G>A intron_variant Intron 4 of 10 1 ENSP00000374143.3 P07510-2
CHRNGENST00000485094.1 linkn.466G>A non_coding_transcript_exon_variant Exon 5 of 5 1

Frequencies

GnomAD3 genomes
AF:
0.0278
AC:
4227
AN:
152134
Hom.:
103
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0283
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0438
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.0292
Gnomad FIN
AF:
0.0332
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.0325
GnomAD3 exomes
AF:
0.0335
AC:
8415
AN:
251456
Hom.:
229
AF XY:
0.0312
AC XY:
4240
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.0274
Gnomad AMR exome
AF:
0.0688
Gnomad ASJ exome
AF:
0.00754
Gnomad EAS exome
AF:
0.0887
Gnomad SAS exome
AF:
0.0276
Gnomad FIN exome
AF:
0.0336
Gnomad NFE exome
AF:
0.0187
Gnomad OTH exome
AF:
0.0303
GnomAD4 exome
AF:
0.0239
AC:
34990
AN:
1461792
Hom.:
762
Cov.:
31
AF XY:
0.0239
AC XY:
17368
AN XY:
727208
show subpopulations
Gnomad4 AFR exome
AF:
0.0272
Gnomad4 AMR exome
AF:
0.0658
Gnomad4 ASJ exome
AF:
0.00708
Gnomad4 EAS exome
AF:
0.114
Gnomad4 SAS exome
AF:
0.0290
Gnomad4 FIN exome
AF:
0.0331
Gnomad4 NFE exome
AF:
0.0182
Gnomad4 OTH exome
AF:
0.0291
GnomAD4 genome
AF:
0.0279
AC:
4244
AN:
152252
Hom.:
103
Cov.:
32
AF XY:
0.0285
AC XY:
2121
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0286
Gnomad4 AMR
AF:
0.0439
Gnomad4 ASJ
AF:
0.00519
Gnomad4 EAS
AF:
0.108
Gnomad4 SAS
AF:
0.0299
Gnomad4 FIN
AF:
0.0332
Gnomad4 NFE
AF:
0.0182
Gnomad4 OTH
AF:
0.0326
Alfa
AF:
0.0214
Hom.:
109
Bravo
AF:
0.0298
TwinsUK
AF:
0.0186
AC:
69
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.0229
AC:
101
ESP6500EA
AF:
0.0155
AC:
133
ExAC
AF:
0.0320
AC:
3885
Asia WGS
AF:
0.0540
AC:
189
AN:
3478
EpiCase
AF:
0.0170
EpiControl
AF:
0.0166

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 25, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive multiple pterygium syndrome Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Congenital Myasthenic Syndrome, Dominant/Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Lethal multiple pterygium syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.3
DANN
Benign
0.96
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.76
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.29
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.27
N
REVEL
Benign
0.18
Sift
Benign
0.37
T
Sift4G
Benign
0.44
T
Polyphen
0.010
B
Vest4
0.033
MPC
0.19
ClinPred
0.0099
T
GERP RS
2.3
Varity_R
0.099

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2289080; hg19: chr2-233406178; COSMIC: COSV101263897; COSMIC: COSV101263897; API